Enlivex Therapeutics Ltd. Logo

Enlivex Therapeutics Ltd.

ENLV | TA

Overview

Corporate Details

ISIN(s):
IL0011319527
LEI:
Country:
Israel
Address:
Weizmann Science Park, 14 Einstein St., 7403618 Ness Ziona
Sector:
Health Care
Industry:
Biotechnology

Description

Enlivex develops immunotherapy solutions for inflammatory diseases and critical conditions.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-12-07 14:40
Inside Information Statement
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Rece…
English 14.8 KB
2022-12-06 14:00
Regulatory News Service
What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has Th…
English 13.8 KB
2022-12-02 14:00
Regulatory News Service
First Patients Dosed in Phase I/II Trial of Enlivexs Off-the-Shelf Cell Therapy…
English 15.9 KB
2022-12-01 20:00
Regulatory News Service
Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Propri…
English 15.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nattaro Labs AB Logo Nattaro Labs AB Sweden NATTA
Neovacs Logo Neovacs France ALNEV
Newron Pharmaceuticals S.p.A. Logo Newron Pharmaceuticals S.p.A. Italy NWRN
NextCell Pharma AB Logo NextCell Pharma AB Sweden NXTCL
NextFerm Technologies Ltd. Logo NextFerm Technologies Ltd. Israel NXFR
NFL Biosciences Logo NFL Biosciences France ALNFL
Nortem BioGroup Logo Nortem BioGroup Spain MLBIO
Novo Nordisk Logo Novo Nordisk Denmark NOVO
NRGene Technologies Ltd. Logo NRGene Technologies Ltd. Israel NRGN
NUFORMIX PLC Logo NUFORMIX PLC United Kingdom NFX